Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) EPS (Weighted Average and Diluted): 2022-2024

Historic EPS (Weighted Average and Diluted) for Molecular Partners Ag (MOLN) over the last 3 years, with Dec 2024 value amounting to -$1.81.

  • Molecular Partners Ag's EPS (Weighted Average and Diluted) rose 538.17% to $478.78 in Q3 2025 from the same period last year, while for Sep 2025 it was $24,364, marking a year-over-year decrease of 12.82%. This contributed to the annual value of -$1.81 for FY2024, which is 14.12% up from last year.
  • Latest data reveals that Molecular Partners Ag reported EPS (Weighted Average and Diluted) of -$1.81 as of FY2024, which was up 14.12% from -$2.10 recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's EPS (Weighted Average and Diluted) ranged from a high of $3.67 in FY2022 and a low of -$2.10 during FY2023.
  • For the 3-year period, Molecular Partners Ag's EPS (Weighted Average and Diluted) averaged around -$0.08, with its median value being -$1.81 (2024).
  • In the last 5 years, Molecular Partners Ag's EPS (Weighted Average and Diluted) tumbled by 157.27% in 2023 and then grew by 14.12% in 2024.
  • Molecular Partners Ag's EPS (Weighted Average and Diluted) (Yearly) stood at $3.67 in 2022, then crashed by 157.27% to -$2.10 in 2023, then rose by 14.12% to -$1.81 in 2024.